Works matching AU Peng, Weiyi


Results: 16
    1

    Development of a RIPK1 degrader to enhance antitumor immunity.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-55006-2
    By:
    • Yu, Xin;
    • Lu, Dong;
    • Qi, Xiaoli;
    • Paudel, Rishi Ram;
    • Lin, Hanfeng;
    • Holloman, Bryan L.;
    • Jin, Feng;
    • Xu, Longyong;
    • Ding, Lang;
    • Peng, Weiyi;
    • Wang, Meng C.;
    • Chen, Xi;
    • Wang, Jin
    Publication type:
    Article
    2
    3
    4
    5
    6
    7

    HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes.

    Published in:
    Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00449-z
    By:
    • Mbofung, Rina M.;
    • McKenzie, Jodi A.;
    • Malu, Shruti;
    • Min Zhang;
    • Weiyi Peng;
    • Chengwen Liu;
    • Kuiatse, Isere;
    • Tieu, Trang;
    • Williams, Leila;
    • Devi, Seram;
    • Ashkin, Emily;
    • Chunyu Xu;
    • Lu Huang;
    • Minying Zhang;
    • Talukder, Amjad H.;
    • Tripathi, Satyendra C.;
    • Hiep Khong;
    • Satani, Nikunj;
    • Muller, Florian L.;
    • Roszik, Jason
    Publication type:
    Article
    8

    A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41690-5
    By:
    • Wei, Cheng-Hsin;
    • Huang, Lu;
    • Kreh, Blair;
    • Liu, Xiuxia;
    • Tyutyunyk-Massey, Liliya;
    • Kawakami, Masanori;
    • Chen, Zibo;
    • Shi, Mi;
    • Kozlov, Serguei;
    • Chan, King C.;
    • Andresson, Thorkell;
    • Carrington, Mary;
    • Vuligonda, Vidyasagar;
    • Sanders, Martin E.;
    • Horowitz, Amir;
    • Hwu, Patrick;
    • Peng, Weiyi;
    • Dmitrovsky, Ethan;
    • Liu, Xi
    Publication type:
    Article
    9

    A novel retinoic acid receptor-γ agonist antagonizes immune checkpoint resistance in lung cancers by altering the tumor immune microenvironment.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41690-5
    By:
    • Wei, Cheng-Hsin;
    • Huang, Lu;
    • Kreh, Blair;
    • Liu, Xiuxia;
    • Tyutyunyk-Massey, Liliya;
    • Kawakami, Masanori;
    • Chen, Zibo;
    • Shi, Mi;
    • Kozlov, Serguei;
    • Chan, King C.;
    • Andresson, Thorkell;
    • Carrington, Mary;
    • Vuligonda, Vidyasagar;
    • Sanders, Martin E.;
    • Horowitz, Amir;
    • Hwu, Patrick;
    • Peng, Weiyi;
    • Dmitrovsky, Ethan;
    • Liu, Xi
    Publication type:
    Article
    10

    Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion.

    Published in:
    Nature Medicine, 2013, v. 19, n. 4, p. 465, doi. 10.1038/nm.3105
    By:
    • Hailemichael, Yared;
    • Dai, Zhimin;
    • Jaffarzad, Nina;
    • Ye, Yang;
    • Medina, Miguel A;
    • Huang, Xue-Fei;
    • Dorta-Estremera, Stephanie M;
    • Greeley, Nathaniel R;
    • Nitti, Giovanni;
    • Peng, Weiyi;
    • Liu, Chengwen;
    • Lou, Yanyan;
    • Wang, Zhiqiang;
    • Ma, Wencai;
    • Rabinovich, Brian;
    • Schluns, Kimberly S;
    • Davis, Richard E;
    • Hwu, Patrick;
    • Overwijk, Willem W
    Publication type:
    Article
    11
    12
    13
    14
    15
    16